We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
AUM
$138M
AUM Growth
+$3.81M
Cap. Flow
+$4.2M
Cap. Flow %
3.03%
Top 10 Hldgs %
35.89%
Holding
98
New
17
Increased
24
Reduced
4
Closed
13

Top Buys

Rank Stock Value
1
AVIR icon
Atea Pharmaceuticals
AVIR
+$2.7M
2
CTRA
Coterra Energy
CTRA
+$2.04M
3
BP icon
BP
BP
+$1.57M
4
INTC icon
Intel
INTC
+$1.47M
5
C icon
Citigroup
C
+$1.18M

Top Sells

Rank Stock Value
1
INTT icon
inTEST
INTT
+$2.95M
2
MRK icon
Merck
MRK
+$1.85M
3
EXEL icon
Exelixis
EXEL
+$1.81M
4
SWN
Southwestern Energy Company
SWN
+$1.63M
5
ET icon
Energy Transfer Partners
ET
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 36.58%
2 Financials 14.24%
3 Technology 13.07%
4 Energy 11.74%
5 Materials 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDR
1
DELISTED
Cloudera, Inc.
CLDR
$6.74M 4.87%
425,000
CYTK icon
2
Cytokinetics
CYTK
$10.7B
$6.43M 4.65%
325,000
ALCO icon
3
Alico
ALCO
$298M
$5.87M 4.25%
165,000
TGB
4
Trekor Metals
TGB
$2.57B
$5.62M 4.06%
2,650,000
NMRK icon
5
Newmark Group
NMRK
$2.75B
$5.1M 3.69%
425,000
SFE
6
DELISTED
Safeguard Scientifics, Inc.
SFE
$4.46M 3.22%
575,000
+25,000
+5% +$170K
FOLD
7
DELISTED
Amicus Therapeutics
FOLD
$4.34M 3.14%
450,000
DRRX
8
DELISTED
DURECT Corp
DRRX
$4.32M 3.12%
265,000
TALO icon
9
Talos Energy
TALO
$2.37B
$3.52M 2.54%
225,000
RIGL icon
10
Rigel Pharmaceuticals
RIGL
$734M
$3.25M 2.35%
75,000
+25,000
+50% +$944K
BGC icon
11
BGC Group
BGC
$5.36B
$2.83M 2.05%
500,000
RNWK
12
DELISTED
RealNetworks Inc
RNWK
$2.62M 1.89%
1,125,000
+100,000
+10% +$292K
RBCAA icon
13
Republic Bancorp
RBCAA
$1.78B
$2.54M 1.83%
55,000
IMGN
14
DELISTED
Immunogen Inc
IMGN
$2.47M 1.79%
375,000
CTRA
15
DELISTED
Coterra Energy
CTRA
$2.44M 1.77%
140,000
+120,000
+600% +$2.04M
B
16
Barrick Mining
B
$58.5B
$2.27M 1.64%
110,000
+35,000
+47% +$789K
ARKR icon
17
Ark Restaurants
ARKR
$20.8M
$2.27M 1.64%
115,000
INTT icon
18
inTEST
INTT
$170M
$2.12M 1.53%
126,600
-218,400
-63% -$2.95M
PFE icon
19
Pfizer
PFE
$141B
$1.96M 1.42%
50,000
AVIR icon
20
Atea Pharmaceuticals
AVIR
$383M
$1.93M 1.4%
+90,000
New +$2.7M
ENLC
21
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$1.92M 1.39%
300,000
CADE
22
DELISTED
Cadence Bancorporation
CADE
$1.88M 1.36%
90,000
RLGT icon
23
Radiant Logistics
RLGT
$414M
$1.88M 1.36%
271,037
-3,963
-1% -$28.7K
OSPN icon
24
OneSpan
OSPN
$575M
$1.79M 1.29%
70,000
SD icon
25
SandRidge Energy
SD
$505M
$1.76M 1.27%
280,000

Similar funds

CM Management's Q2 2021 Portfolio in Review

As of Q2 2021, CM Management held 98 positions worth $138M, up 2.8% from $135M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $4.2M of net new capital in Q2 2021, opening 17 new positions and adding to 24 existing holdings. Its largest new stake was Atea Pharmaceuticals: 90,000 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was inTEST, an estimated $2.95M trimmed.

  • CM Management's largest Q2 2021 buy was Atea Pharmaceuticals: 90,000 shares worth $1.93M.
  • CM Management added most to Coterra Energy in Q2 2021, an estimated $2.04M increase.
  • CM Management's biggest Q2 2021 reduction was inTEST, cutting an estimated $2.95M.
  • CM Management fully exited Merck in Q2 2021, selling an estimated $1.85M.
  • CM Management's ten largest holdings make up 36% of its $138M portfolio in Q2 2021.
  • CM Management opened 17 new positions and closed 13 in Q2 2021.
  • CM Management's portfolio value rose 2.8% quarter-over-quarter to $138M.

Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.